Although methods of blood collection, preparation and storage have improved significantly, potential complications and efficacy, especially of allogeneic -Donor- RBC transfusions, are still a major concern. Allogeneic RBC transfusions in patients having cardiac surgery is associated with infection, ischemic postoperative morbidity, longer hospital stay, increased early and late mortality and high indirect hospitalization costs.